Is EDTXF or RYLD a better dividend investment in 2026?

EDTXF currently yields 203.25% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: EDTXF offers higher current income.

What is the dividend yield difference between EDTXF and RYLD?

EDTXF has a forward dividend yield of 203.25% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 190.86 percentage points.

Home › Compare › EDTXF vs RYLD

EDTXF vs RYLD: Dividend Comparison 2026

EDTXF yields 203.25% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EDTXF wins by $131.04M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EDTXF

● Live price

203.25%

Share price

$0.98

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$131.09M

Annual income

$66,614,308.55

Full EDTXF calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — EDTXF vs RYLD

📍 EDTXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EDTXF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EDTXF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EDTXF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EDTXF

Annual income on $10K today (after 15% tax)

$17,276.42/yr

After 10yr DRIP, annual income (after tax)

$56,622,162.27/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, EDTXF beats the other by $56,619,881.73/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EDTXF + RYLD for your $10,000?

EDTXF: 50%RYLD: 50%

100% RYLD50/50100% EDTXF

Portfolio after 10yr

$65.57M

Annual income

$33,308,495.76/yr

Blended yield

50.80%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EDTXF buys

RYLD buys

No recent congressional trades found for EDTXF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEDTXFRYLD

Forward yield	203.25% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$131.09M ✓	$45.3K
Annual income after 10y	$66,614,308.55 ✓	$2,682.98
Total dividends collected	$123.65M ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EDTXF vs RYLD ($10,000, DRIP)

Year	EDTXF Portfolio	EDTXF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$31,025	$20,325.20	$11,939	$1,239.34	+$19.1K → EDTXF
2	$92,131	$58,933.98	$14,158	$1,382.89	+$78.0K → EDTXF
3	$262,139	$163,558.41	$16,682	$1,532.59	+$245.5K → EDTXF
4	$715,413	$434,925.03	$19,537	$1,687.64	+$695.9K → EDTXF
5	$1,874,812	$1,109,319.79	$22,752	$1,847.20	+$1.85M → EDTXF
6	$4,722,949	$2,716,900.45	$26,355	$2,010.43	+$4.70M → EDTXF
7	$11,450,101	$6,396,545.74	$30,376	$2,176.45	+$11.42M → EDTXF
8	$26,744,592	$14,492,983.16	$34,847	$2,344.43	+$26.71M → EDTXF
9	$60,254,103	$31,637,389.98	$39,800	$2,513.54	+$60.21M → EDTXF
10	$131,086,199	$66,614,308.55	$45,269	$2,682.98	+$131.04M → EDTXF

EDTXF vs RYLD: Complete Analysis 2026

EDTXF — Stock

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Full EDTXF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this EDTXF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EDTXF vs SCHD EDTXF vs JEPI EDTXF vs O EDTXF vs KO EDTXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.